Jacobs & CO Thermo Fisher Scientific Inc. Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Jacobs & CO holds 13,733 shares of TMO stock, worth $7.26 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

13,733

Previous 13,894 1.16%

Holding current value

$7.26 Million

Previous $7.68 Million 10.56%

% of portfolio

0.85%

Previous 0.81%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$531.86 - $624.21 $85,629 - $100,497	-161 Reduced 1.16%	13,733 $8.49 Million
Q2 2024 Jul 12, 2024	SELL	$541.52 - $599.02 $105,054 - $116,209	-194 Reduced 1.38%	13,894 $7.68 Million
Q1 2024 Apr 12, 2024	SELL	$528.82 - $599.43 $41,247 - $46,755	-78 Reduced 0.55%	14,088 $8.19 Million
Q4 2023 Jan 17, 2024	BUY	$431.41 - $532.94 $1.06 Million - $1.31 Million	2,460 Added 21.01%	14,166 $7.52 Million
Q3 2023 Oct 13, 2023	BUY	$498.29 - $574.41 $2.48 Million - $2.86 Million	4,977 Added 73.96%	11,706 $5.93 Million
Q2 2023 Jul 11, 2023	BUY	$508.46 - $591.13 $3.06 Million - $3.56 Million	6,017 Added 845.08%	6,729 $3.51 Million
Q4 2022 Jan 13, 2023	SELL	$484.71 - $571.37 $12,117 - $14,284	-25 Reduced 3.39%	712 $392,000
Q1 2021 Apr 05, 2021	SELL	$439.85 - $518.83 $21,992 - $25,941	-50 Reduced 6.35%	737 $336,000
Q4 2020 Jan 12, 2021	BUY	$435.06 - $527.66 $21,753 - $26,383	50 Added 6.78%	787 $366,000
Q4 2019 Jan 29, 2020	SELL	$271.93 - $328.04 $3,535 - $4,264	-13 Reduced 1.73%	737 $239,000
Q1 2019 Apr 29, 2019	BUY	$212.17 - $273.72 $159,127 - $205,290	750 New	750 $205,000

Others Institutions Holding TMO

# of Institutions

2,836

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $207B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account